NYEEMAH KENNEDY

MOUNT MORRIS, PA

This page merges CMS profile IDs: 11308011, 11395194 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$692.27

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $490.20 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $490.2019

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ViiV Healthcare Company $271.668
Gilead Sciences, Inc. $49.402
Lilly USA, LLC $45.742
ABBVIE INC. $38.582
Novo Nordisk AS $30.472
NOVARTIS PHARMACEUTICALS CORPORATION $19.791
ITI, Inc. $19.031
Phadia US Inc. $15.531

By program year

Program yearAmountRecords
2021 $34.952
2023 $167.128
2024 $490.2019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067584514 Phadia US Inc. $15.53 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087125746 Novartis Pharmaceuticals Corporation $19.79 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096604977 Novo Nordisk Inc $14.56 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097434686 Novo Nordisk Inc $15.91 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104052210 ABBVIE INC. $16.28 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104052212 ABBVIE INC. $22.30 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112701485 ViiV Healthcare Company $19.67 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112720838 ViiV Healthcare Company $22.32 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112731231 ViiV Healthcare Company $117.18 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112736841 ViiV Healthcare Company $23.39 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112749580 ViiV Healthcare Company $21.86 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112791946 ViiV Healthcare Company $15.00 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112805117 ViiV Healthcare Company $31.49 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112820135 ViiV Healthcare Company $20.75 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739828 Gilead Sciences, Inc. $24.94 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739830 Gilead Sciences, Inc. $24.46 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135249735 Lilly USA, LLC $27.81 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135253745 Lilly USA, LLC $17.93 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143255660 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.03 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 11308011, 11395194

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.